Funding

2/2021-1/2024
“Paclitaxel-Picelles for Triple-Negative Breast Cancer Therapy” funded by the BMBF (German Science Ministry) with over 2 Mio € for all partners (AG Maurer/223,856€) together with AG Lammers, AG Morgenroth (UK Aachen), AG Wendler (Fraunhofer PAZ), CTCR Aachen and EPO (Berlin)

11/2019-10/2022
“Entwicklung einer verbesserten, nebenwirkungsarmen Immuntherapie basierend auf Tumor-gerichteter und aktivierbarer Immunreaktionsauslösung (Taktira)“ funded by Europäische Fonds für regionale Entwicklung (EFRE, Förderkennzeichen 0801765) (220,347 € für die Molekulare Gynäkologie/AG Maurer, insgesamt Fördervolumen von 2,85 Mio €/davon 1,17 Mio € für die Uniklinik RWTH Aachen)

12/2019-11/2022
“Importance of vascular prostate specific mebrane antigen for the endogenous radiotherapy of triple-negative breast cancer” funded by the German Cancer Aid (367,955 €) together with AG Morgenroth, Uniklinik RWTH Aachen

7/2019-6/2021
“Funktionale miRNA-Untersuchung der Metastasierung in einem individualisierten, patienten-spezifischen Brustkrebsstammzellmodell“ funded by START – Uniklinik RWTH Aachen (102,000 €)

12/2018-12/2019
„In vitro-Challenge – Entwicklung und Etablierung von individuellen biomimetischen Humantumormodellen zur Entwicklung und Testung neuer Therapeutika“ funded by the BMBF (50.000 €)

11/2018-10/2021
“IRAK2 induces differentiation in breast cancer stem cells” funded by the DFG (215,000 €)

1/2018-12/2018
IZKF “Advanced Program” 3D-Advanced Tumor-tissue Application Chemotherapy-concept (3D-ATAC) (20,000 €)

1/2018-12/2021
Memono – Metabolisches Monitoring in an Organ-on-chip-System Funding through Land Baden-Württemberg (468,000 €) together with AG Urban

1/2018-6/2020
Part of the GADETA Eurostars Grant “Developing tools to assess efficacy and safety of the promising TEG treatment for solid tumors” Funding by the European Union (1,6000,000 €) together with AG Schamel/Minguet (BIOSS Freiburg), Gadeta B.V. (Netherlands), CellTool (Germany) and Hubrecht Organoid Technology (Netherlands)

1/2017-6/2017
Bridge-funding (Forschungskommission Freiburg): Postdoctoral position with lab funds to evaluate the effects of Histone deacetylase inhibitor Methylstat on breast cancer stem cells (35,000 €)

1/2016-12/2017
ChemMon3D – novel 3D models of cancer replacing animal models. Funding through Land Baden-Württemberg (160,000 €) together with AG Urban (IMTEK)

1/2014-12/1017
Member of SFB850, Project C8: “Role of EMT and cellular motility in cancer stem cells isolated from triple negative breast cancer” (480,000 €)

6/2013-12/2016
DKTK Juniorgroup, ”Targeting the kinome to induce differentiation in human breast cancer stem cells” (600,000 €)

6/2010-6/2013
Department of Defense Postdoctoral Fellowship (BC093655), independant research grant “Establishment, Analysis, and Differentiation of Basal-Like Breast Cancer Stem Cells” (320,000 $ with overhead for 3 years)